康臣葯業：2021年度報告.pdf

1、Contrast MediumGastroenterology MedicinesKidney Medicines腎科藥物Hepatobiliary Medicines肝膽藥物Orthopedics Medicines骨科藥物Dermatologic Medicines皮膚科藥物對比劑消化系統藥物Women and Children Medicines婦兒藥物年度報告Annual Report2021 1ANNUAL REPORT 2021 年度報告Contents 目錄Corporate Information公司資料2-4Chairmans Statement主席報告5-20Financi

2、al Highlights財務摘要21Management Discussion and Analysis管理層討論及分析22-33Directors and Senior Management Profile董事及高層管理人員履歷34-47Corporate Governance Report企業管治報告48-69Report of Directors董事局報告70-94Independent Auditors Report獨立核數師報告95-107Consolidated Statement of Profit or Loss綜合損益表108Consolidated Statement o

3、f Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表109Consolidated Statement of Financial Position綜合財務狀況表110-111Consolidated Statement of Changes in Equity綜合權益變動表112-113Consolidated Cash Flow Statement綜合現金流量表114Notes to the Consolidated Financial Statements綜合財務報表附註115-235Five-Year Financial

4、Summary五年財務摘要236CONSUN PHARMACEUTICAL GROUP LIMITED 康臣葯業集團有限公司2公司資料Corporate InformationDIRECTORSExecutive DirectorsMr.An Meng(Chairman)(appointed as executive Director on 24 March 2021 and appointed as chairman on 9 July 2021)Mr.An Yubao(Founder,Chairman)(resigned,effective from 9 July 2021)Ms.Li Q

5、ian(Founder,Vice Chairlady,Chief Executive Officer)Professor Zhu QuanMr.Xu Hanxing(appointed on 24 March 2021)Non-Executive DirectorMs.Zhang Lihua(appointed on 9 July 2021)Independent Non-Executive DirectorsMr.Su YuanfuMr.Feng ZhongshiMs.Chen YujunAUDIT COMMITTEEMs.Chen Yujun(Chairlady)Mr.Su YuanfuM

6、r.Feng ZhongshiNOMINATION COMMITTEEMr.Su Yuanfu(Chairman)Mr.An Meng(appointed on 9 July 2021)Ms.Chen YujunMr.An Yubao(resigned,effective from 9 July 2021)REMUNERATION COMMITTEEMr.Feng Zhongshi(Chairman)Ms.Li QianMr.Su YuanfuCOMPANY SECRETARYMr.Yau Chi Ming(CPA)董事執行董事安猛先生（主席）（於2021年3月24日獲委任為 執行董事，及於2